Literature DB >> 28964650

Community-acquired Legionnaires' disease at a medical center in northern Taiwan.

Wei-Fang Kao1, Jann-Tay Wang2, Wang-Huei Sheng3, Yee-Chun Chen1.   

Abstract

BACKGROUND/
PURPOSE: Legionella pneumophila had been recognized as an important pathogen for community-acquired pneumonia. We aimed to investigate clinical features and outcomes of patients with Legionnaires' disease at a tertiary medical center in northern Taiwan.
METHODS: From June 2012 to February 2017, a retrospective review of adult community-acquired. Legionnaires' disease at a medical center was conducted. All Legionella infections were confirmed by positive urinary Legionella antigen assay, sera indirect immunofluorescence assay, or sputum culture for Legionella. Literature review of Legionnaires' disease from Medline and PubMED websites was performed.
RESULTS: A total of 32 cases of Legionnaires' disease were identified. Their mean age was 64.3 years, with male predominance (27 cases, 84.3%). The underlying diseases were varied and most were attributed to chronic disorders, such as diabetes mellitus (31%) and cigarette smoking (40.6%). The most common symptoms were cough (68%) and fever (59.3%). More than half of patients (18, 56.2%) with Legionnaires' disease could initially present with extrapulmonary manifestations. Sixteen (50%) patients had delay in initiation of appropriate antibiotic therapy. Patients without adequately initiation of appropriate antibiotic therapy had higher proportion (11 of 16, 68.7%) of intensive care unit admission than patients with adequate initiation (5 of 16, 31.2%). Our results inferred that a delay in treatment might result in worsening of disease severity and the need for more intensive management. Overall mortality rate was 21.8%. Development of vasopressor requirement is an independent risk factor associated with mortality.
CONCLUSION: Legionnaires' disease in Taiwan frequently present with extrapulmonary manifestations. Patients with hemodynamic instability that need vasopressor therapy associated with mortality.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Community-acquired pneumonia; Fluoroquinolone; Legionnaires' disease; Macrolide

Mesh:

Substances:

Year:  2017        PMID: 28964650     DOI: 10.1016/j.jmii.2017.08.018

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  3 in total

1.  Investigation of a cluster of Legionnaires' disease during the outbreak of coronavirus disease 2019 pandemic in northeastern Taiwan, June 2021.

Authors:  Jung-Jr Ye; Jun-Yuan Zheng; Ya-Hsuan Chen; Ya-Ling Kao; Yu-Chin Kao; Shao-Wen Chao
Journal:  J Microbiol Immunol Infect       Date:  2022-05-05       Impact factor: 10.273

2.  Performance of a multiplex PCR pneumonia panel for the identification of respiratory pathogens and the main determinants of resistance from the lower respiratory tract specimens of adult patients in intensive care units.

Authors:  Sze Hwei Lee; Sheng-Yuan Ruan; Sung-Ching Pan; Tai-Fen Lee; Jung-Yien Chien; Po-Ren Hsueh
Journal:  J Microbiol Immunol Infect       Date:  2019-11-23       Impact factor: 4.399

3.  Are Fluoroquinolones or Macrolides Better for Treating Legionella Pneumonia? A Systematic Review and Meta-analysis.

Authors:  Annie S Jasper; Jackson S Musuuza; Jessica S Tischendorf; Vanessa W Stevens; Shantini D Gamage; Fauzia Osman; Nasia Safdar
Journal:  Clin Infect Dis       Date:  2021-06-01       Impact factor: 20.999

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.